[1]
Kwon, D.H. et al. 2025. Corrigendum to "Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway" [EXCLI Journal 2021;20:968-982]. EXCLI Journal. 24, (Mar. 2025), 452–453. DOI:https://doi.org/10.17179/excli2025-8358.